SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Q3 Trading Update

28 Oct 2020 07:00

RNS Number : 3962D
Elementis PLC
28 October 2020
 

Elementis plc

Q3 Trading Update

Resilient performance, in line with management expectations

On track for significant year end net debt reduction

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 30 September 2020.

Third quarter business performance

 

While trading improved versus the second quarter, COVID-19 continues to impact the Group with volumes down approximately 13% on the prior year. Pricing remained resilient across all businesses except for Chromium. As a result of cost savings and supply chain efficiencies, overall performance in the third quarter was in line with management expectations.

· Coatings performed well in Q3, with revenue broadly in line with the prior year period, as continued resilience in decorative applications was supported by improved industrial demand. The business remains on track for improved operating margins versus the prior year.

 

· Personal Care sales were materially lower than both the prior year period and Q2, particularly in higher margin cosmetics, due to the continuation of social and travel restrictions as a result of COVID-19.

 

· Talc volumes recovered from the Q2 trough but as expected were below prior year. Automotive demand sequentially improved and coatings gained market share.

· Chromium performance was in line with Q2 levels, but materially down on the prior year period, reflective of lower demand at key customers and sustained industry pricing pressure, particularly in the rest of the world. Current Q4 trading indicates some recovery versus a difficult Q3.

 

· Energy continues to experience very weak market conditions with rig counts and activity levels remaining at subdued Q2 levels.

 

In the third quarter we have continued to successfully deliver against our Innovation, Growth and Efficiency strategy. We launched 3 new products, delivered $9m of new business and remain on track for delivery of $15m in year cost savings.

For 2021, our new business and innovation pipelines are encouraging, and we have made good progress underpinning $10m of supply chain cost efficiencies. Our new AP Actives plant in India remains on track for mid-2021 start up.

Liquidity and balance sheet

 

Elementis has a proven cash generative business model, with average operating cash conversion above 90% over the last 3 years and the Group is on track to deliver a significant reduction in net debt by year end.

 

The Group continues to operate with ample liquidity, with over $300m immediately available through committed lending facilities. As announced in September, the relaxation of the Group net debt/EBITDA* banking covenant to 3.75x, agreed in Q1 2020 as part of the Group's response to COVID19, has now been extended, at minimal cost, to include the two testing points in 2021 (i.e. 30 June and 31 December).

 

Outlook

 

Whilst market conditions remain challenging and future visibility is limited, we have seen solid demand in October and have a robust order book for November. We have a clear, focused strategy and we continue to tightly manage the business in terms of fixed costs and working capital to address changes in demand. An action plan to improve the financial performance of Energy is underway.

 

 

Commenting on the performance, CEO, Paul Waterman said,

"Overall performance has been resilient and in line with our expectations. Nevertheless, the macroeconomic outlook remains uncertain and our focus remains on managing our operations well and executing our growth, innovation and efficiency agenda.

In recent years we have focused Elementis on high quality, high margin activities in Personal Care, Coatings and Talc as these businesses have enduring positions of strength in structural growth markets. I am confident we will emerge from this crisis well positioned for improved top and bottom line performance and future value creation."

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

David Allchurch

 

 

Note: * Pre IFRS 16

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMRBRTMTITBJM
Date   Source Headline
29th Nov 201311:00 amRNSTotal Voting Rights
31st Oct 201311:00 amRNSTotal Voting Rights
25th Oct 20137:00 amRNSInterim Management Statement
16th Oct 20131:00 pmRNSAdditional Listing
1st Oct 20139:00 amRNSDirectorate Change
30th Sep 201311:00 amRNSTotal Voting Rights
6th Sep 20131:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20134:00 pmRNSBlocklisting Interim Review
30th Aug 20131:00 pmRNSTotal Voting Rights
28th Aug 201311:00 amRNSDirector/PDMR Shareholding
23rd Aug 20134:30 pmRNSHolding(s) in Company
2nd Aug 20134:00 pmRNSHolding(s) in Company
31st Jul 20134:01 pmRNSHolding(s) in Company
31st Jul 20134:00 pmRNSDirector/PDMR Shareholding
31st Jul 20131:00 pmRNSTotal Voting Rights
30th Jul 20137:00 amRNSInterim Results
22nd Jul 20137:00 amRNSDirectorate Change
3rd Jul 201311:00 amRNSHolding(s) in Company
28th Jun 201312:42 pmRNSTotal Voting Rights
3rd Jun 201312:00 pmRNSTotal Voting Rights
22nd May 201311:00 amRNSAdditional Listing
7th May 20131:00 pmRNSDirector/PDMR Shareholding
7th May 20137:00 amRNSDirectorate Change
30th Apr 201311:00 amRNSTotal Voting Rights
25th Apr 20133:12 pmRNSResult of AGM
25th Apr 20137:00 amRNSAGM Statement
12th Apr 201311:00 amRNSDirector/PDMR Shareholding
3rd Apr 20134:10 pmRNSDirector/PDMR Shareholding
28th Mar 201311:30 amRNSTotal Voting Rights
25th Mar 201311:00 amRNSHolding(s) in Company
21st Mar 20139:30 amRNS2012 Annual Financial Report & Notice of 2013 AGM
6th Mar 201311:00 amRNSAdditional Listing
6th Mar 201311:00 amRNSHolding(s) in Company
6th Mar 201311:00 amRNSHolding(s) in Company
1st Mar 201311:00 amRNSBlocklisting Interim Review
28th Feb 201311:00 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSFinal Results
25th Feb 201311:00 amRNSHolding(s) in Company
20th Feb 20137:00 amRNSAcquisition
8th Feb 201311:00 amRNSDirector Declaration
1st Feb 201311:00 amRNSDirector/PDMR Shareholding
31st Jan 201311:00 amRNSTotal Voting Rights
24th Jan 201311:00 amRNSHolding(s) in Company
24th Jan 201311:00 amRNSHolding(s) in Company
17th Jan 201311:00 amRNSDirector/PDMR Shareholding
2nd Jan 201311:00 amRNSTotal Voting Rights
30th Nov 201211:00 amRNSTotal Voting Rights
7th Nov 201211:00 amRNSAdditional Listing
31st Oct 20121:00 pmRNSTotal Voting Rights
26th Oct 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.